Furthermore, epigenetic reprograming of NRF2 can lead to its reactivation and subsequent induction of downstream target genes involved in cellular protection (Figure 2E), further suggesting the use of KEAP1 within the NRF2 pathway as a potential target for cancer treatment. The gene discussed is KEAP1; the disease is cancer.